As of 2025-09-18, the Relative Valuation of Akero Therapeutics Inc (AKRO) is (49.43) USD. This relative valuation is based on P/E multiples. With the latest stock price at 42.18 USD, the upside of Akero Therapeutics Inc based on Relative Valuation is -217.2%.
The range of the Relative Valuation is (49.42) - (49.56) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 13.9x - 14.0x | 14.0x |
| Forward P/E multiples | 13.8x - 14.0x | 13.9x |
| Fair Price | (49.42) - (49.56) | (49.43) |
| Upside | -217.2% - -217.5% | -217.2% |
| Date | P/E |
| 2025-09-16 | -12.00 |
| 2025-09-15 | -12.07 |
| 2025-09-12 | -12.24 |
| 2025-09-11 | -12.66 |
| 2025-09-10 | -12.18 |
| 2025-09-09 | -12.57 |
| 2025-09-08 | -12.56 |
| 2025-09-05 | -12.60 |
| 2025-09-04 | -12.40 |
| 2025-09-03 | -12.85 |
| 2025-09-02 | -12.80 |
| 2025-08-29 | -13.16 |
| 2025-08-28 | -13.22 |
| 2025-08-27 | -13.57 |
| 2025-08-26 | -13.56 |
| 2025-08-25 | -13.25 |
| 2025-08-22 | -13.87 |
| 2025-08-21 | -13.60 |
| 2025-08-20 | -13.51 |
| 2025-08-19 | -13.41 |
| 2025-08-18 | -13.69 |
| 2025-08-15 | -13.91 |
| 2025-08-14 | -14.11 |
| 2025-08-13 | -13.61 |
| 2025-08-12 | -13.53 |
| 2025-08-11 | -13.60 |
| 2025-08-08 | -14.21 |
| 2025-08-07 | -14.21 |
| 2025-08-06 | -14.87 |
| 2025-08-05 | -13.96 |
| 2025-08-04 | -13.70 |
| 2025-08-01 | -13.63 |
| 2025-07-31 | -13.76 |
| 2025-07-30 | -13.44 |
| 2025-07-29 | -13.38 |
| 2025-07-28 | -13.87 |
| 2025-07-25 | -14.24 |
| 2025-07-24 | -14.23 |
| 2025-07-23 | -14.60 |
| 2025-07-22 | -14.61 |
| 2025-07-21 | -14.47 |
| 2025-07-18 | -14.67 |
| 2025-07-17 | -15.30 |
| 2025-07-16 | -15.10 |
| 2025-07-15 | -14.58 |
| 2025-07-14 | -14.85 |
| 2025-07-11 | -14.53 |
| 2025-07-10 | -14.65 |
| 2025-07-09 | -14.40 |
| 2025-07-08 | -14.19 |